Randomized study of dexamethasone treatment for delayed emesis, anorexia and fatigue induced by irinotecan

Supportive Care in Cancer

Volumn 11, Issue 8, 2003, Pages 528-532

  Inoue, Akira ^a   Yamada, Yasuhide ^b   Matsumura, Yasuhiro ^b   Shimada, Yasuhiro ^b   Muro, Kei ^b   Gotoh, Masahiro ^b   Hamaguchi, Tetsuya ^b   Mizuno, Toshiro ^b   Shirao, Kuniaki ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Anorexia; Delayed emesis; Dexamethasone; Fatigue; Irinotecan

Indexed keywords

DEXAMETHASONE; GRANISETRON; IRINOTECAN; MITOMYCIN; PLACEBO;

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FEVER; HICCUP; HUMAN; HYPERTENSION; INSOMNIA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ADULT; AGED; ANOREXIA; ANTIEMETICS; ANTINEOPLASTIC AGENTS; DEXAMETHASONE; FATIGUE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PLACEBOS; SEVERITY OF ILLNESS INDEX; VOMITING;

EID: 0043236024     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-003-0488-y     Document Type: Article

References (21)

1. Barbounis V, Koumakis G, Vassilomanolakis M, et al (2001) Control of irinotecan-induced diarrhea by octreotide after loperamide failure. Support Care Cancer 9:258-260
2. Boku N, Ohtsu A, Shimada Y, et al (1999) Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer. J Clin Oncol 17:319-323
3. Burstein HJ, Manola J, Younger J, et al (2000) Docetaxel administration on a weekly basis for metastatic breast cancer. J Clin Oncol 18:1212-1219
4. Cunningham D, Pyrhšnen S, James RD, et al (1998) Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352:1413-1418
5. Gralla RJ, Osoba D, Kris MG, et al (1999) Recommendations for the Use of Antiemetics: Evidense-Based, Clinical Practice Guidelines. J Clin Oncol 17:2971-2994
6. Green MR, Harper M, Safa A, et al (2000) Irinotecan in the management of patients with pancreatic cancer. Oncology (Suppl 14):31-33
7. Hardy JR, Rees E, Ling J, et al. (2001) A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med 15:3-8
8. Inoue A, Saijo N (2001) Recent advances in the chemotherapy of non-small cell lung cancer. Jpn J Clin Oncol 31:299-304
9. Kehrer DF, Sparreboom A, Verweij J, et al (2001) Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients. Clin Cancer Res 7:1136-1141
10. Noda K, Nishiwaki Y, Kawahara M, et al (2002) Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346:85-91
11. Portenoy RK, Itri LM (1999) Cancer-related fatigue: guidelines for evaluation and management. Oncologist 4:1-10
12. Rougier P, Van Cutsem E, Bajetta E, et al (1998) Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 352:1407-1412
13. Saltz LB, Cox JV, Blanke C, et al (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 343:905-914
14. Seidman AD, Hudis CA, Albanel J, et al (1998) Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer. J Clin Oncol 16:3353-3361
15. Stone P, Richards M, Hardy J (1998) Fatigue in patients with cancer. Eur J Cancer 34:1670-1676
16. Takeda Y, Kobayashi K, Akiyama Y, et al (2001) Prevention of irinotecan (CPT-11)-induced diarrhea by oral alkalization combined with control of defecation in cancer patients. Int J Cancer 92:269-275
17. The Italian group for antiemetic research (1995) Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med 332:1-5
18. The Italian group for antiemetic research (1997) Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. J Clin Oncol 15:124-130
19. The Italian group for antiemetic research (2000) Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy. N Engl J Med 342:1554-1559
20. Yamada Y, Shirao K, Hyodo I, et al (2003) Phase II study of irinotecan plus mitomycin C in patients with fluoropyrimidine-resistant advanced colorectal cancer. Ann Oncol 13 (Suppl 5):86
21. Organization for pharmaceutical safety and research. Drug information of irinotecan (in Japanese). http://www.pharmasys.gr.jp/downfiles/PDF/400014_4240404A1032_1_06.pdf. Cited 17 Mar 2003)